Search

Your search keyword '"Polkinghorne, Kr"' showing total 285 results

Search Constraints

Start Over You searched for: Author "Polkinghorne, Kr" Remove constraint Author: "Polkinghorne, Kr"
285 results on '"Polkinghorne, Kr"'

Search Results

1. Clinical Adjudication of Hemodialysis Catheter-Related Bloodstream Infections: Findings from the REDUCCTION Trial.

2. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

3. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

4. Impact of haemodialysis hours on outcomes in older patients

5. Projecting the incidence and costs of major cardiovascular and kidney complications of type 2 diabetes with widespread SGLT2i and GLP-1 RA use: a cost-effectiveness analysis

6. The burden and trend of diseases and their risk factors in Australia, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019

7. Effect of a Multifaceted Intervention on the Incidence of Hemodialysis Catheter Dysfunction in a National Stepped-Wedge Cluster Randomized Trial

8. Multifaceted intervention to reduce haemodialysis catheter related bloodstream infections: REDUCCTION stepped wedge, cluster randomised trial

9. CKD Biomarkers, Cognitive Impairment, and Incident Dementia in an Older Healthy Cohort

10. Relationship Between Urinary Phosphate and All-Cause and Cardiovascular Mortality in a National Population-Based Longitudinal Cohort Study

11. Study protocol for The GOAL Trial: comprehensive geriatric assessment for frail older people with chronic kidney disease to increase attainment of patient-identified goals—a cluster randomised controlled trial.

12. Conversion of urine protein-creatinine ratio or urine dipstick to urine albumin-creatinine ratio for use in CKD screening and prognosis

13. Risk factors for major adverse kidney events in the first year after acute kidney injury

14. Attitudes and Practices of Australian Nephrologists Toward Implementation of Clinical Genomics

15. Variability and trends over time and across centres in haemodialysis weekly duration in Australia and New Zealand

16. Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney disease

17. Health-related quality of life among patients with comorbid diabetes and kidney disease attending a codesigned integrated model of care: A longitudinal study

18. Patient-reported barriers and outcomes associated with poor glycaemic and blood pressure control in co-morbid diabetes and chronic kidney disease

19. Arteriovenous access practices in Australian and New Zealand dialysis units

20. The impact of an integrated diabetes and kidney service on patients, primary and specialist health professionals in Australia: A qualitative study

21. Associations of Chronic Kidney Disease Markers with Cognitive Function: A 12-Year Follow-Up Study

22. Can we IMPROVE cardiovascular outcomes through phosphate lowering in CKD? Rationale and protocol for the IMpact of Phosphate Reduction on Vascular End-points in Chronic Kidney Disease (IMPROVE-CKD) study

23. Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trial

24. Natural killer cell function predicts severe infection in kidney transplant recipients

25. Associations of Chronic Kidney Disease Markers with Cognitive Function: A 12-Year Follow-Up Study

26. A simple score can identify kidney transplant recipients at high risk of severe infection over the following 2 years

27. Risk Indices in Deceased-donor Organ Allocation for Transplantation: Review From an Australian Perspective.

28. Relative risks of Chronic Kidney Disease for mortality and End Stage Renal Disease across races is similar

29. Age and Association of Kidney Measures With Mortality and End-stage Renal Disease

30. Past Decline Versus Current eGFR and Subsequent Mortality Risk

31. Patient reported barriers are associated with low physical and mental well-being in patients with co-morbid diabetes and chronic kidney disease

33. Seroresponses and safety of 13-valent pneumococcal conjugate vaccination in kidney transplant recipients

34. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis

35. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate

36. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data

37. Developing a Set of Core Outcomes for Trials in Hemodialysis: An International Delphi Survey

38. Cystatin C estimated glomerular filtration rate and all-cause and cardiovascular disease mortality risk in the general population: AusDiab study

39. Low versus high dialysate calcium concentration in alternate night nocturnal hemodialysis: A randomized controlled trial

40. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis

41. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis

42. Standardised outcomes in nephrology - Haemodialysis (SONG-HD): Study protocol for establishing a core outcome set in haemodialysis

43. The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications

44. The Association between Body Mass Index and Mortality in Incident Dialysis Patients

45. 25-hydroxyvitamin D Levels and chronic kidney disease in the AusDiab (Australian Diabetes, Obesity and Lifestyle) study

46. High rates of albuminuria but not of low eGFR in Urban Indigenous Australians: the DRUID Study

48. Water quality in conventional and home haemodialysis.

49. Comparison of the prevalence and mortality risk of CKD in Australia using the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) Study GFR estimating equations: the AusDiab (Australian Diabetes, Obesity and...

Catalog

Books, media, physical & digital resources